UICC members demonstrate innovative leadership and commitment to the global cancer community and help make an impact beyond their national borders. UICC has longstanding partnerships with some of the largest cancer organisations in the world, including the National Cancer Institute, Centre for Disease Control, World Cancer Research Fund International, Dutch Cancer Society, American Cancer Society, Swiss Cancer League and Norwegian Cancer Society. These members provide funding for UICC’s core priorities and have provided multi-year support for fellowships, advocacy and essential programmes.
At the World Cancer Congress in 2012, four UICC members announced they would ramp-up their support to priority activities which benefit the global cancer community. Working in partnership with UICC, leading members have pledged financial support and expertise to help accelerate key programmes and create tangible impacts. We are proud to share the following commitments:
- American Cancer Society announced a $2 million pledge over the next three years for global advocacy, Global Access to Pain Relief Initiative (GAPRI) and ACSBI Fellowships
- Dutch Cancer Society announced a minimum of $1.8 million over the next three years for global advocacy and the Cervical Cancer Initiative (CCI)
- LiveStrong Foundation announced a $500,000 pledge over the next three years for global advocacy and GAPRI
- Canadian Cancer Society announced a $300,000 over three years for global advocacy and CCI
We are excited about the scaling-up of our partnerships with these strong and influential cancer societies over the coming years and welcoming other partners from around the world.
“The American Cancer Society has supported the fight against cancer since our founding nearly 100 years ago, and this investment represents a critical step forward in eliminating global suffering from this disease. This crucial commitment of new and significant financial, executive and staff resources will help address an urgent need as the Society and UICC work together to help save even more lives from cancer worldwide.”
Dr John Seffrin, CEO, American Cancer Society
“We have achieved a great deal in the Netherlands. Overall the 5-year survival rate for Dutch cancer patients has increased to 60%. We have contributed to this result through our investments in raising awareness, information and patient support and cancer research. We are proud of our impact at a national level. However, we recognise that in today’s interconnected world, we must also step-up and be more active in the global cancer community. For this reason, we are scaling up our partnership with UICC.”
Michel Rudolphie, Chief Executive Officer, Dutch Cancer Society